suzanne-hodsden-articles

91. Teleflex Pays $1B For Vascular Solutions, Enters Peripheral And Coronary Vascular Market 12/6/2016

    Teleflex has entered into a definitive agreement to acquire Vascular Solutions for $1B, a move that will launch Teleflex into the coronary and peripheral vascular markets.

92. Boston Scientific Builds Structural Heart Biz With Neovasc Deal 12/5/2016

    Boston Scientific continues to diversify its foothold in the cardiovascular space, signing a definitive agreement to acquire select technologies and manufacturing capabilities from Neovasc, a Canadian biological tissue business specializing in elements used to build transcatheter heart valves. 

93. Device Industry Reacts To Trump's Nominations For HHS and CMS 12/2/2016

    President-elect Donald Trump has nominated U.S. Rep. Tom Price (R-GA.) as secretary of the Department of Health and Human Services (HHS), and tabbed Seema Verma, a healthcare consultant, to head the Centers for Medicare and Medicaid Services (CMS). 

94. Medtronic Signs Its First Integrated Health Solutions Agreement In U.S. 12/1/2016

    Medtronic has inked an Integrated Health Solutions agreement with University Hospitals Cleveland Medical Center (UH), the first agreement of its kind signed by Medtronic in the U.S. Together, the organizations will implement Medtronic’s operational models to streamline workflow and efficiency in select catherization (cath) and electrophysiology (EP) laboratories.

95. LG Electronics “Diving Head-First” Into Competitive Medical Imaging Market 11/30/2016

    LG Electronics signaled its entry into the medical imaging market with the announcement of three new devices: a clinical review monitor, a surgical monitor, and a digitized x-ray detector for radiography.

96. Are Porous Polymers The Key To Non-Toxic Gold Circuits In Biomedical Wearables? 11/29/2016

    National Institute of Standards and Technology (NIST) researchers have uncovered a possible solution for incorporating non-toxic, but brittle, gold circuitry into sensing platforms that are flexible enough to be worn inside or outside the body for an extended period of time.

97. FDA Considers NDA For Intarcia's “Disruptive” Diabetes Implant 11/28/2016

    FDA is considering a new drug application (NDA) from biopharmaceutical company Intarcia Therapeutics for ITCA 650, an investigational therapy for type II diabetes that uses an implanted mini-pump to continuously release the drug. Intarcia CEO Kurt Graves commented that the disruptive technology, if approved, would be the first and only injection free glucagon-like peptide-1 (GLP-1) receptor agonist therapy.

98. Boston Scientific, Penn State's Cardiac Sensor System Predicts Heart Failure Events 11/23/2016

    Sensor technology attached to cardiac implants can successfully predict heart failure events 70 percent of the time, according to an international team of scientists that included representatives from Boston Scientific and Penn State Medical Center. 

99. Verily, Novartis Push Back Start Date For Human Testing Of Smart Contact Lenses 11/22/2016

    Verily and Novartis have pushed back the launch date for a clinical trial to test “smart” contact lenses in human participants, a spokesperson from Novartis told Reuters. Despite a now indefinite start date, the companies report the technology is “progressing steadily.”

100. Should FDA Regulate Medical Device Repair, Maintenance? 11/21/2016

     FDA has received testimony from several industry, hospital, and patient advocates who weighed in on the possible regulation of medical device maintenance.